TENAX THERAPEUTICS, INC. Amortization of Intangible Assets
TENAX THERAPEUTICS, INC. (TENX) reported Amortization of Intangible Assets of $0 for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2017-11-09
- TENAX THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2017-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2017-06-30 was $0.00.
- TENAX THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2017-03-31 was $0.00.
- TENAX THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2016-12-31 was $0.00.
- TENAX THERAPEUTICS, INC. amortization of intangible assets for fiscal 2016 was $0.00.
- TENAX THERAPEUTICS, INC. amortization of intangible assets for fiscal 2015 was $70.30K, a 13.05% increase from fiscal 2014.
- TENAX THERAPEUTICS, INC. amortization of intangible assets for fiscal 2014 was $62.19K, a 11.36% increase from fiscal 2013.
- TENAX THERAPEUTICS, INC. amortization of intangible assets for fiscal 2013 was $55.84K, a 23.60% increase from fiscal 2012.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 8 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $0.00 derived: sum of 3 quarters · filed 2017-08-09 | $0.00 derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | $0.00 derived: sum of 3 quarters · filed 2017-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 derived: sum of 3 quarters · filed 2017-11-09 | $0.00 10-K · filed 2017-03-16 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | |||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | |||||
| 2015-10-31 | $0.00 10-Q · filed 2015-12-10 | $0.00 10-Q · filed 2015-12-10 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $25.00K 10-Q · filed 2016-11-09 | ||||
| 2015-07-31 | $0.00 10-Q · filed 2015-09-09 | $18.30K derived: sum of 2 quarters · filed 2017-03-16 | ||||
| 2015-04-30 | $18.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $70.30K 10-K · filed 2017-03-16 | ||||
| 2015-03-31 | $18.43K 10-Q · filed 2016-05-10 | |||||
| 2015-01-31 | $18.00K 10-Q · filed 2015-03-17 | $35.00K derived: sum of 2 quarters · filed 2015-12-10 | $52.00K 10-Q · filed 2015-03-17 | $68.89K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-10-31 | $17.00K 10-Q · filed 2015-12-10 | $34.00K 10-Q · filed 2015-12-10 | $50.90K derived: sum of 3 quarters · filed 2017-03-16 | $66.89K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-07-31 | $16.71K 10-Q · filed 2015-09-09 | $17.00K 10-Q · filed 2014-09-15 | $33.90K derived: sum of 2 quarters · filed 2017-03-16 | $49.90K derived: sum of 3 quarters · filed 2017-03-16 | $64.89K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-04-30 | $17.19K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $33.19K derived: sum of 2 quarters · filed 2017-03-16 | $48.19K derived: sum of 3 quarters · filed 2017-03-16 | $62.19K 10-K · filed 2017-03-16 | ||
| 2014-01-31 | $16.00K 10-Q · filed 2015-03-17 | $31.00K derived: sum of 2 quarters · filed 2015-03-17 | $45.00K 10-Q · filed 2015-03-17 | $60.84K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-10-31 | $15.00K 10-Q · filed 2014-12-15 | $30.00K 10-Q · filed 2014-12-15 | $44.84K derived: sum of 3 quarters · filed 2016-03-14 | $58.84K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-07-31 | $15.00K 10-Q · filed 2014-09-15 | $29.84K derived: sum of 2 quarters · filed 2016-03-14 | $43.84K derived: sum of 3 quarters · filed 2016-03-14 | $56.84K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-04-30 | $14.85K derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $28.84K derived: sum of 2 quarters · filed 2016-03-14 | $41.84K derived: sum of 3 quarters · filed 2016-03-14 | $55.84K 10-KT · filed 2016-03-14 | ||
| 2013-01-31 | $14.00K 10-Q · filed 2014-03-17 | $27.00K derived: sum of 2 quarters · filed 2014-03-17 | $41.00K 10-Q · filed 2014-03-17 | $53.18K derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-10-31 | $13.00K 10-Q · filed 2013-12-17 | $27.00K 10-Q · filed 2013-12-17 | $39.18K derived: sum of 3 quarters · filed 2013-12-17 | $50.18K derived: sum of 4 quarters · filed 2013-12-17 | ||
| 2012-07-31 | $13.00K 10-Q · filed 2013-09-17 | $26.18K derived: sum of 2 quarters · filed 2013-09-17 | $37.18K derived: sum of 3 quarters · filed 2013-09-17 | $47.18K derived: sum of 4 quarters · filed 2013-09-17 | ||
| 2012-04-30 | $13.18K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $24.18K derived: sum of 2 quarters · filed 2013-06-26 | $34.18K derived: sum of 3 quarters · filed 2013-06-26 | $45.18K 10-K · filed 2013-06-26 | ||
| 2012-01-31 | $11.00K 10-Q · filed 2013-03-18 | $21.00K derived: sum of 2 quarters · filed 2013-03-18 | $32.00K 10-Q · filed 2013-03-18 | |||
| 2011-10-31 | $10.00K 10-Q · filed 2012-12-14 | $21.00K 10-Q · filed 2012-12-14 | ||||
| 2011-07-31 | $41.00K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |